Welcome to the Wangensteen Lab
Our lab is conducting exciting research on the genetics of liver repopulation and hepatocellular carcinoma (HCC). We have developed two highly innovative in vivo genetic screening paradigms to elucidate genetic pathways involved in carcinogenesis and liver repopulation in the setting of toxic injury. We aim to discover pathways that lead to drug sensitivity and resistance in HCC. One of our assays involves CRISPR activation screening in vivo in the liver, the first-ever use of this type of screening in live mice.
Welcome new lab members!
Congratulations Kirk Wangensteen on being awarded the McCabe Fund Pilot Award!
The Wangensteen Lab welcomed new members in May and June:
Jie Chen, MD
Morgan Preziosi, PhD
Sofi Vergara, undergraduate student
Gastroenterology Division Events
© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.